Susan Thornton, Ph.D.
Dr. Thornton is a life sciences executive with a track record of success in building and managing businesses through technology transfer, product development, and targeted marketing programs. She is currently CEO and Managing Partner for BioVerum Partners, a healthcare advisory services firm that assists clients in maximizing the value of their life sciences businesses. Prior to BioVerum, Dr. Thornton was an Executive in Residence with MDS Capital, a leading healthcare venture capital firm. Dr. Thornton also held the position of President, Global Clinical Research and Central Labs for MDS Inc, a top-five contract clinical research organization operating out of 22 countries. In this position, Dr. Thornton had responsibility for all facets of the business and guided the organization through major change following the acquisition of six regional companies. Prior to MDS, Dr Thornton was Director of Worldwide Business Development for SmithKline Beecham, now GlaxoSmithKline, where she led teams in the negotiation and acquisition of new products for the pharmaceutical business. She also served as Project Manager, leading multidisciplinary project teams in the development of new biotechnology products. Dr. Thornton has substantial experience in international business development, deal sourcing and due diligence, integration and restructuring, and the achievement of sustained financial growth through the development of new business strategies and operating efficiencies. She earned her Ph.D in Molecular Biology from the University of Pennsylvania and an M.S. Microbiology and B.S. Psychology from Pennsylvania State University.